跳至主要内容
临床试验/NCT03804762
NCT03804762已完成不适用

Feasibility of the Third Space Robotic and Endoscopic Cooperative Surgery(TS-RECS) for Treating Gastric Stromal Tumor

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年4月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
the rate of adverse events

研究概览

简要总结

The third space robotic and endoscopic cooperative surgery (TS-RECS) combines the endoscopic techniques and the merits of Da Vinci surgical robot, such as flexible and precise instruments, tremors filtering system and a 3-D surgical view. TS-RECS takes full advantage of the methodology of the third space, making it possible to dissect gastric GISTs (gastrointestinal stromal tumors) entirely without the damage of mucosal layer. Here, this study preliminarily assessed the feasibility, safety and effectivity of the novel hybrid operation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with gastric GISTs originating from muscularis propria diagnosed by EUS (endoscopic ultrasound);
  • The maximal cross-sectional diameter of tumor ranging from 2cm to 5cm, or the maximal cross-sectional diameter of tumor <2cm but with malignant potential ( irregular shape, cystic space, heterogeneity and rapid growth during follow-ups ) ;
  • No evidence of tumor metastasis on all per-operative evaluations;

排除标准

  • Patients with serious systemic comorbidities, such as severe heart failure, respiratory failure, uncontrolled hypertension;
  • Patients with advanced malignant tumor;
  • Patients were required the emergency operation by complete intestinal obstruction, perforation and hemorrhage caused by the tumor;
  • 4.Patients with ulcer penetration into tumors;
  • Patients with the contraindications for general anesthesia;
  • Patients were pregnant or younger than 18 years old;

研究组 & 干预措施

patients received treatment of TS-RECS

Experimental

干预措施: the third space robotic and endoscopic cooperative surgery (Procedure)

结局指标

主要结局

the rate of adverse events

时间窗: through study completion, an average of 6 months

Adverse events included intraoperative adverse (full-thickness perforation, hemorrhage, injury of visceral organs and vessel, and anaesthesia complications), and postoperative adverse events (infectious complications, intra-abdominal /intraluminal bleeding, gastric stasis and leakage)

次要结局

  • rate of en bloc resection(1 day)
  • the rate of intact mucosal layer(1 day)
  • operation time(1 day)
  • estimated blood loss(1 day)
  • time to oral diet(30 days)
  • duration of postoperative hospital stay(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A New Method: the Third Space Robotic and Endoscopic... | 临床试验